
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.55 | 0.55 | 0.55 | 0 | 0 | CS |
4 | 0.0072 | 1.32645541636 | 0.5428 | 0.55 | 0.5396 | 389699 | 0.54623928 | CS |
12 | 0.232399 | 73.1732582706 | 0.317601 | 0.556 | 0.2202 | 1713499 | 0.4737573 | CS |
26 | -0.77 | -58.3333333333 | 1.32 | 1.97 | 0.2202 | 2065400 | 0.52000433 | CS |
52 | -9.2 | -94.358974359 | 9.75 | 10.5 | 0.2202 | 1733769 | 1.18568129 | CS |
156 | -8.03 | -93.5897435897 | 8.58 | 12.37 | 0.2202 | 908934 | 3.52616513 | CS |
260 | -2.35 | -81.0344827586 | 2.9 | 20.04 | 0.2202 | 1077115 | 4.09524277 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관